(702) 683-8946

Monday - Friday 9am to 5pm



Buy and register domain names online from CRWE Domains. Web hosting, spam-free email, web marketing, secure SSL Certificates and more




Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com




CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform




Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business




Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.


Latest News Releases From The Newsroom

Xplore Secures Additional Million-Dollar Contract with Major Telecommunications Provider for Two Rugged Tablet Platforms

May 10th, 2016

AUSTIN, TX / CRWEPRESSRELEASE / May 10, 2016 - Xplore Technologies Corp. (NASDAQ: XPLR), manufacturer of the world’s broadest range of high-quality rugged tablet computers, announced today it has secured a $1 million order for its Xplore B. Read more

Proxy Contest Ends with May 10 Special Meeting Cancellation as Dissidents Obtain Negligible Shareholder Support

May 09th, 2016

Vancouver, BC / CRWEPRESSRELEASE / May 9, 2016 –Taseko Mines Limited (TSX: TKO; NYSE MKT: TGB) (“Taseko” or the “Company”) today confirmed cancellation of a scheduled special meeting of shareholders set for May 10, 2016 after dissident shar. Read more

Harris Corporation Awarded $405 Million Foreign Military Sales IDIQ Contract for Tactical Radios

May 09th, 2016

Highlights: Contract includes radios and associated equipment and support services Products include SINCGARS and SpearNet™ radios Contract awarded by U.S. Army Communications-Electronics Command (CECOM) ROCHESTER, N.Y. / CRWEPRES. Read more

GW Pharmaceuticals to Present at the Bank of America Merrill Lynch 2016 Healthcare Conference on 10 May

May 04th, 2016

London, UK / CRWEPRESSRELEASE / May 4, 2016 - GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from i. Read more

Google Self-Driving Car Project and FCA Announce First-of-its-kind Collaboration

May 03rd, 2016

London / CRWEPRESSRELEASE / May 3, 2016 - Google expands self-driving test program with the all-new 2017 Chrysler Pacifica Hybrid minivan FCA engineers to work alongside Google engineers to integrate self-driving technology into vehicle Sel. Read more

Japanese Patent grants for IMP321 in Cancer

May 02nd, 2016

SYDNEY, AUSTRALIA / CRWEPRESSRELEASE / May 2, 2016 - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) ("Prima", the "Company") announces the granting of patent number 5908210 entitled "Use of Recombinant LAG-3 or the Derivatives thereof for Eliciting Monocy. Read more

GW Pharmaceuticals to Report Q2, Half-Year Financial Results and Host Conference Call on 5 May, 2016

April 28th, 2016

London, UK / CRWEPRESSRELEASE / April 28, 2016 - GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics fro. Read more

Delta Air Lines and Bombardier Sign Largest C Series order for up to 125 Aircraft

April 28th, 2016

Delta orders 75 firm CS100 aircraft with options for 50 more CS100 aircraft As the U.S. CS100 launch customer, order helps Delta reshape and modernize domestic fleet Bombardier and Delta to hold joint press conference at 10:00 a.m. EDT in Mira. Read more

Update: Bombardier to report First Quarter 2016 Financial Results on Thursday, April 28, 2016

April 26th, 2016

Annual and special meeting of shareholders to be held on Friday, April 29, 2016, as planned Montréal / CRWEPRESSRELEASE / April 26, 2016 – Bombardier (TSX: BBD.B) announced today that it has brought forward the publication of its. Read more

InVivo Therapeutics Reports Conversion of a Fourth Patient Implanted with the Neuro-Spinal Scaffold(TM) in the INSPIRE Study

April 26th, 2016

- Four Out of First Six Patients Have Converted from Complete to Incomplete Spinal Cord Injury – CAMBRIDGE, Mass. / CRWEPRESSRELEASE / April 26, 2016 – InVivo Therapeutics Holdings Corp. (NVIV) today announced that the sixth-implanted . Read more